Home › NDC Lookup › RxCUI directory › RxCUI 197816

Indapamide 2.5 MG Oral Tablet — RxCUI 197816

RxNorm drug concept · Semantic clinical drug
RxCUI 197816 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197816
Official nameIndapamide 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asindapamide (as indapamide hemihydrate) 2.5 MG Oral Tablet
FDA products mapped13
Package NDCs mapped18
Reported Medicaid activity (SDUD)32,997 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Indapamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Indapamide is a 'water pill' (diuretic) that's approved for two things: lowering high blood pressure, and reducing the fluid buildup (swelling) that can happen with congestive hear...
  • The label recommends taking it once a day in the morning — that way, most of the diuretic (fluid-removing) effect happens during daytime hours so you're not running to the bathroom...
  • When should I take indapamide, and does it matter if I take it with food?
  • The most common ones are headache, dizziness, fatigue, muscle cramps, and more frequent urination — especially when you first start. Low potassium is also pretty common with this t...
📖 Read our full Indapamide guide →

🕸️ Concept Web — How Indapamide 2.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Indapamide 2.5 MG Oral Tablet RxCUI 197816

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Indapamide 5764
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Indapamide Oral Tablet 370682
    • Indapamide Oral Product 1156302
    • Indapamide Pill 1156303
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Indapamide 2.5 MG 316080

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Indapamide 2.5 MG SCDC · 316080
  • Indapamide Oral Tablet SCDF · 370682
  • Indapamide Oral Product SCDG · 1156302
  • Indapamide Pill SCDG · 1156303

📦 FDA Products & Package NDCs

13 products · 18 package NDCs
18 package NDCs map to RxCUI 197816 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-2571-11 100 TABLET, FILM COATED in 1 BOTTLE (0228-2571-11) Indapamide Actavis Pharma, Inc. 2007-01-02
00228-2571-96 1000 TABLET, FILM COATED in 1 BOTTLE (0228-2571-96) Indapamide Actavis Pharma, Inc. 2007-01-02
00228-2597-11 100 TABLET, FILM COATED in 1 BOTTLE (0228-2597-11) Indapamide Actavis Pharma, Inc. 2007-01-02
00228-2597-96 1000 TABLET, FILM COATED in 1 BOTTLE (0228-2597-96) Indapamide Actavis Pharma, Inc. 2007-01-02
16571-0875-01 100 TABLET in 1 BOTTLE (16571-875-01) Indapamide Rising Pharma Holdings, Inc. 2023-06-22
16571-0876-01 100 TABLET in 1 BOTTLE (16571-876-01) Indapamide Rising Pharma Holdings, Inc. 2023-06-22
50090-7826-01 90 TABLET, FILM COATED in 1 BOTTLE (50090-7826-1) Indapamide A-S Medication Solutions 2025-12-16
51407-0024-01 100 TABLET, FILM COATED in 1 BOTTLE (51407-024-01) Indapamide Golden State Medical Supply, Inc. 2018-01-01
51407-0025-01 100 TABLET, FILM COATED in 1 BOTTLE (51407-025-01) Indapamide Golden State Medical Supply, Inc. 2018-01-01
62559-0510-01 100 TABLET, FILM COATED in 1 BOTTLE (62559-510-01) Indapamide ANI Pharmaceuticals, Inc. 2017-04-24
62559-0511-01 100 TABLET, FILM COATED in 1 BOTTLE (62559-511-01) Indapamide ANI Pharmaceuticals, Inc. 2017-04-24
63629-1954-01 100 TABLET, FILM COATED in 1 BOTTLE (63629-1954-1) Indapamide Bryant Ranch Prepack 2021-06-29
68788-7247-01 100 TABLET, FILM COATED in 1 BOTTLE (68788-7247-1) Indapamide Preferred Pharmaceuticals Inc. 2018-08-20
68788-7247-03 30 TABLET, FILM COATED in 1 BOTTLE (68788-7247-3) Indapamide Preferred Pharmaceuticals Inc. 2018-08-20
68788-7247-06 60 TABLET, FILM COATED in 1 BOTTLE (68788-7247-6) Indapamide Preferred Pharmaceuticals Inc. 2018-08-20
68788-7247-09 90 TABLET, FILM COATED in 1 BOTTLE (68788-7247-9) Indapamide Preferred Pharmaceuticals Inc. 2018-08-20
72162-1767-01 100 TABLET, FILM COATED in 1 BOTTLE (72162-1767-1) Indapamide Bryant Ranch Prepack 2023-10-05
72189-0591-60 60 TABLET, FILM COATED in 1 BOTTLE (72189-591-60) Indapamide Direct_Rx 2024-10-30
Observed labelers: Actavis Pharma, Inc. (4) · Preferred Pharmaceuticals Inc. (4) · ANI Pharmaceuticals, Inc. (2) · Bryant Ranch Prepack (2) · Golden State Medical Supply, Inc. (2) · Rising Pharma Holdings, Inc. (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.